european countries some european countries like france finland iceland have decided that they will start giving astra zeneca again in fact some of them already have however they will only give it to populations of old age groups and that's because when the evidence will move things they said in their press conference last week was that the cases that they had seen of blood clotting that could possibly be linked to astra zeneca. in the younger age groups now trust in seneca has completely gone off the edge of a cliff across the european union a recent survey by hugo found that the majority of people just didn't think that this vaccine was safe so this new information about the fact that it's quite as effective as we previously would lead to believe may seem like a very small thing but it really could erode trust even further. microbiologist simon clarke told us such data revisions could hit confidence in the pharmaceutical giant and it shot. fundamental tenet in science that you don't pick and choose which states are you presenting but it appears that for some reason that's what's happene

there hasn't been fully convincing all the european countries some european countries like france finland iceland have decided that they will start giving astra zeneca again in fact some of them already have however they will only now give it to populations of old age groups and that's because when the d.n.a. would be evidence was things they said in their press conference last week was that the cases that they had seen of blood clotting that could possibly be linked to astra zeneca who in the younger age groups now trusting are it's just an affair has completely gone off the edge of a cliff across the european union a recent survey by new girl found the majority of people just didn't think that this vaccine was safe so this new information about the fact that it's not quite as effective as we previously were led to believe may seem like a very small thing but it really could erode trust even further. well let's go live now to microbiologist simon clark of reading university thanks for joining us again to have you on the program today. what do you think the company overestimated this vaccine's ef